Device Trial Radar · NCT01940185
A Post-Approval Study of the LINX® Reflux Management System
Last checked: Nov 20, 2026Latest source record: Jan 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
Jun 30, 2012
Primary completion
Jun 30, 2023
Study completion Jun 30, 2023
Sponsor
- Lead sponsor
- Torax Medical IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 12, 2013
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Post-Approval Study of the LINX® Reflux Management System in a prospective, multicenter, single-arm study, with patients as their own control to monitor the safety and efficacy of the LINX implant procedure and device in a post-approval environment to supplement existing safety and efficacy data.
Conditions
- Gastroesophageal Reflux Disease (GERD)
Interventions
LINX deviceDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction of total GERD-HRQL scoreTime frame: 6 months, 12 months, and annually to 60 months
1 more outcomes with a free account
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Keck Medical Center of Univeristy of Southern California
Los Angeles, California
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.